[go: up one dir, main page]

MX9306337A - INDOLIN-2-ONAS TRICICLICAS Y TETRACICLICAS 3,3-DISUSTITUIDAS AND COMPARISONS PHARMACEUTICAL THAT CONTAIN THEM, FOR THE TREATMENT OF DISORDERS OF KNOWLEDGE. - Google Patents

INDOLIN-2-ONAS TRICICLICAS Y TETRACICLICAS 3,3-DISUSTITUIDAS AND COMPARISONS PHARMACEUTICAL THAT CONTAIN THEM, FOR THE TREATMENT OF DISORDERS OF KNOWLEDGE.

Info

Publication number
MX9306337A
MX9306337A MX9306337A MX9306337A MX9306337A MX 9306337 A MX9306337 A MX 9306337A MX 9306337 A MX9306337 A MX 9306337A MX 9306337 A MX9306337 A MX 9306337A MX 9306337 A MX9306337 A MX 9306337A
Authority
MX
Mexico
Prior art keywords
disorders
knowledge
treatment
triciclicas
tetraciclicas
Prior art date
Application number
MX9306337A
Other languages
Spanish (es)
Inventor
Richard Alan Earl
Melvin John Myers
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of MX9306337A publication Critical patent/MX9306337A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se relaciona con compuestos de la fórmula I, loscuales se ha demostrado que favorecen la liberación del neurotransmisoracetilcolina, y por lo tanto, pueden ser útiles como intermediariosquímicos y como agentes farmacológicos en el tratamiento de enfermedadesen seres humanos, tal como la Enfermedad Aizheimer y otros trastornos queincluyen el aprendizaje y el conocimiento, en los que se encuentranconcentraciones subnormales de este neuroquímico. Los compuestos de lapresente invención tienen la fórmula. (Ver Fórmula).The present invention relates to compounds of formula I, which have been shown to promote the release of the neurotransmitter acetylcholine, and therefore may be useful as chemical intermediates and as pharmacological agents in the treatment of diseases in humans, such as Aizheimer's Disease and other disorders that include learning and knowledge, in which subnormal concentrations of this neurochemical are found. The compounds of the present invention have the formula. (See Formula).

MX9306337A 1992-10-13 1993-10-12 INDOLIN-2-ONAS TRICICLICAS Y TETRACICLICAS 3,3-DISUSTITUIDAS AND COMPARISONS PHARMACEUTICAL THAT CONTAIN THEM, FOR THE TREATMENT OF DISORDERS OF KNOWLEDGE. MX9306337A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96052292A 1992-10-13 1992-10-13

Publications (1)

Publication Number Publication Date
MX9306337A true MX9306337A (en) 1995-01-31

Family

ID=25503278

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306337A MX9306337A (en) 1992-10-13 1993-10-12 INDOLIN-2-ONAS TRICICLICAS Y TETRACICLICAS 3,3-DISUSTITUIDAS AND COMPARISONS PHARMACEUTICAL THAT CONTAIN THEM, FOR THE TREATMENT OF DISORDERS OF KNOWLEDGE.

Country Status (8)

Country Link
EP (1) EP0664810A1 (en)
JP (1) JPH08502293A (en)
AU (1) AU6242294A (en)
CA (1) CA2146000A1 (en)
IL (1) IL107251A0 (en)
MX (1) MX9306337A (en)
WO (1) WO1994009009A1 (en)
ZA (1) ZA937604B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
CN112624972A (en) * 2019-09-24 2021-04-09 中国人民解放军军事科学院军事医学研究院 Acridone compound and medical application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US5278045A (en) * 1990-02-28 1994-01-11 Du Pont Merck Pharmaceutical Company Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function

Also Published As

Publication number Publication date
IL107251A0 (en) 1994-01-25
JPH08502293A (en) 1996-03-12
EP0664810A1 (en) 1995-08-02
CA2146000A1 (en) 1994-04-28
AU6242294A (en) 1994-05-09
WO1994009009A1 (en) 1994-04-28
ZA937604B (en) 1995-04-13

Similar Documents

Publication Publication Date Title
AR002289A1 (en) DERIVATIVES OF ACETAMIDE, PROCEDURE TO PREPARE THEM, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE APPLICATIONS OF SUCH ASANIOLYTICAL COMPOUNDS AND IN THE TREATMENT OF IMMUNO-INFLAMMATORY DISEASES.
ES2119124T3 (en) BENZIMIDAZOLES USEFUL FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS.
MX9101869A (en) CYCLOSPORINS, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND PROCEDURE FOR THE PRODUCTION OF THE SAME
PA8452001A1 (en) DERIVATIVES OF MACROLIDES C-4 "SUBSTITUTED
PA8442001A1 (en) DERIVATIVES OF CONDENSED BICYCLIC PIRIMIDINE
MX9301847A (en) PHARMACEUTICALLY ACTIVE BICYCLE-HETEROCICLIC AMINES
ES2161291T3 (en) N- (INDOL-2-CARBONIL) AMIDAS AND DERIVATIVES AS INHIBITORS OF THE GLUCOGENO FOSFORILASA.
GT200000014A (en) DERIVATIVES OF QUINOLIN - 2 - ONA SUBSTITUTED WITH HETEROARILO USEFUL AS ANTI-BANERIGAN AGENTS.
ES2170104T3 (en) INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS.
MX9306234A (en) OXYDOLES AND AZAOXOINDOLES 1-SUBSTITUTED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BR0315008A (en) Neurologically Active Compounds
ES2179094T3 (en) DERIVATIVES OF CYCLIC AMIDES AS ANTAGONISTS OF NEUROQUININA A.
BR0312232A (en) Caspase inhibitors and their uses
ES2164088T3 (en) ANTAGONISTS OF THE SUBSTANCE P FOR THE TREATMENT OF EMESIS.
PA8508201A1 (en) HETEROCICLO-ALQUILSULFONIL PIRAZOLO DERIVATIVES AS ANTI-INFLAMMATORY / ANALGESIC AGENTS
KR870700599A (en) Carboxylic acid derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses thereof
PA8457001A1 (en) DERIVATIVES OF 2- (4-ARIL OR HETEROARIL-PIPERAZIN-I-ILMETIL) -1H-INDOL
ES2072263T3 (en) 4-AMINOPYRIDINE DERIVATIVES.
DK1032556T3 (en) Pharmaceutically active compounds and methods of use
ES2093782T3 (en) PIRIDAZINDIONAS AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS.
MX9300203A (en) DISUBSTITUTED POLYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
MX9300205A (en) DISUBSTITUTED POLYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
NO885386D0 (en) BISPHENYLALKYL PIPERZINE DERIVATIVES, A PROCESS OF PREPARATION AND A PHARMACEUTICAL PREPARATION.
ES2189956T3 (en) DERIVATIVES OF QUINOLINA, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
DE69429856D1 (en) SUBSTITUTED CAPROLACTAME AND THEIR DERIVATIVES USED FOR TREATING HIV DISEASE